Furthermore, the upregulated expression of IL-33, IL-25, and TSLP is observed in patients with AD, and IL-35 could cause the suppression of these cells, which in turn will also result in the inhibition of a Th2 immune response [42] p. 35, [68]. The gene discussed is TSLP; the disease is Alzheimer disease.